Intravascular Imaging-Guided Versus Angiography- Guided PCI in Patients With DES-ISR
1 other identifier
observational
1,500
1 country
1
Brief Summary
This study aimed to compare the clinical and angiographic outcomes of patients with DES-ISR who underwent repeat PCI with intravascular imaging or angiographic guidance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 9, 2025
CompletedFirst Posted
Study publicly available on registry
December 22, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
December 22, 2025
December 1, 2025
10 months
December 9, 2025
December 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MACE
Major adverse cardiovascular events following PCI
3-year
Secondary Outcomes (2)
Stent expansion
Intraprocedural
MSA
Intraprocedural
Study Arms (2)
Intravascular imaging -guidance
Individuals underwent intravascular imaging -guided PCI for lesions diagnosed with ISR
Angiography-guidance
Individuals underwent angiography-guided PCI for lesions diagnosed with ISR
Interventions
Percutaneous Coronary Intervention for ISR
Eligibility Criteria
The first-time drug-eluting stent in-stent restenosis (DES-ISR) who underwent repeat percutaneous coronary intervention (re-PCI) under angiographic guidance or combined IVUS guidance.
You may qualify if:
- (1) Patients with DES-ISR lesions; (2) Life expectancy of at least 1 year; (3) DES-ISR lesions occurring for the first time in native coronary arteries and suitable for re-PCI based on angiographic findings.
You may not qualify if:
- (1) Bare-metal stent in-stent restenosis (BMS-ISR). (2) Non-DES-ISR lesions. (3) Incomplete clinical and angiographic data. (4) Poor quality of IVUS or angiographic images. (5) Recurrent DES-ISR. (6) Optical coherence tomography (OCT) guidance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanjing First Hospital
Nanjing, Jiangsu, 210006, China
Related Publications (1)
Wang YF, Xu T, Meng PN, You W, Xu Y, Kong XH, Wu XQ, Wu ZM, Zhao MY, Jia HB, Wang F, Ye F. Optical coherence tomography versus angiography to guide percutaneous coronary intervention in patients with in-stent restenosis: an observational study. Coron Artery Dis. 2025 Mar 1;36(2):108-116. doi: 10.1097/MCA.0000000000001458. Epub 2024 Dec 3.
PMID: 39620882RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fei Ye
Nanjing First Hospital, Nanjing Medical University, 210006 Nanjing, Jiangsu, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- chief physician
Study Record Dates
First Submitted
December 9, 2025
First Posted
December 22, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
August 1, 2027
Last Updated
December 22, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Due to privacy and ethical limitations, the data generated and analyzed in current study are not publicly available but could be obtained from principal investigator upon the approval of ethics committee